Semler Scientific, Inc.

Company Information

Industry Electromedical & Electrotherapeutic Apparatus
SIC Code 3845
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 51 E CAMPBELL AVE, CAMPBELL, CA, 95008
Mailing Address 51 E CAMPBELL AVE, CAMPBELL, CA, 95008
Phone 8777744211
Fiscal Year End 1231
EIN 261367393

Financial Overview

FY2024 FY

$68.18M
Revenue
$239.83M
Total Assets

Recent SEC Filings

Form Type Date Filed Document
SCHEDULE 13G Passive beneficial ownership (>5%) February 11, 2026 View on SEC
4 Insider stock transaction report January 16, 2026 View on SEC
4 Insider stock transaction report January 16, 2026 View on SEC
4 Insider stock transaction report January 16, 2026 View on SEC
SCHEDULE 13D/A Beneficial ownership amendment January 16, 2026 View on SEC
8-K Current report of material events January 16, 2026 View on SEC
SCHEDULE 13D/A Beneficial ownership amendment January 16, 2026 View on SEC
4 Insider stock transaction report January 16, 2026 View on SEC
4 Insider stock transaction report January 16, 2026 View on SEC
8-K Current report of material events January 13, 2026 View on SEC

Material Events

8-K Strategy Change January 13, 2026
High Impact
  • Semler Scientific strategically invested $48.8 million in 581 Bitcoins, positioning it as a long-term treasury asset and hedge against inflation.
  • Stockholders approved a significant merger with Strive, Inc. on January 13, 2026, fundamentally altering Semler's business operations and future direction.
View Analysis
8-K Layoffs December 12, 2025
High Impact
  • Semler Scientific announced a major plan to cut costs, including laying off approximately 37% of its employees.
  • This significant workforce reduction and cost-cutting effort is happening as the company prepares for a pending merger with Strive, Inc.
View Analysis

Related Companies

Companies in the same industry (SIC: 3845)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.